Monocytes harboring cytomegalovirus: Interactions with endothelial cells, smooth muscle cells, and oxidized low-density lipoprotein: Possible mechanisms for activating virus delivered by monocytes to sites of vascular injury

Circulation Research

Volumn 81, Issue 1, 1997, Pages 8-16

  Guetta, Esther ^a,c   Guetta, Victor ^a   Shibutani, Tomoko ^b   Epstein, Stephen E ^b  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; Chloramphenicol acetyltransferase assay; Immediate early protein; Transfection; Viral gene expression regulation

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; LIPOPROTEIN METABOLISM; MONOCYTE; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS TRANSMISSION;

EID: 0030905779     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.1.8     Document Type: Article

References (58)

1. Huang ES, Kowalik T. The pathogenicity of human cytomegalovirus: an overview. In: Beker Y, Darai G, eds. Molecular Aspects of Human Cytomegalovirus Diseases. Berlin, Germany: Springer-Verlag; 1993:1-45.
2. Bruggeman CA. Cytomegalovirus and latency: an overview. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;64:325-333.
3. Melnick JL, Adam E, Debakey ME. Cytomegalovirus and atherosclerosis. Bioessays. 1995;17:899-903.
4. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 1994;265:391-394.
5. Taylor-Wiedeman J, Sissons JP, Borysiewicz LK, Sinclair JH. Monocytes are a major site of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol. 1991;72:2059-2064.
6. Taylor-Wiedeman J, Sissons JP, Sinclair JH. Induction of endogenous cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol. 1994;68:1597-1604.
7. Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Jeor SC. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood. 1992;80:170-178.
8. Minton EJ, Tysoe C, Sinclair JH, Cessans JPG. Human cytomegalovirus infection of the monocyte/macrophase lineage in bone marrow. J Virol. 1994;68:4017-4021.
9. Kondo K, Kaneshima H, Mocarski ES. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci U S A. 1994;91:11879-11883.
10. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis. 1986;153:478-488.
11. Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA. Human cytomegalovirus productively infects primary differentiated macrophages. J Virol. 1991;65:6581-6588.
12. Mocarski ES. Cytomegalovirus biology and replication. In: Roizman B, Whitley R, Lopez C, eds. The Human Herpesviruses. New York, NY: Raven Press Publishers; 1993:173-226.
13. Boom R, Geelen JL, Sol CJ, Raap AK, Minnaar RP, Klaver BP, Van der Noorda J. Establishment of a rat cell line inducible for the expression of human cytomegalovirus immediate-early gene products by protein synthesis inhibition. J Virol. 1986;58:851-859.
14. Stein J, Volk HD, Liebenthal C, Kruger DH, Prosch S. Tumor necrosis factor a stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J Gen Virol. 1993;74:2333-2338.
15. Abrahamson TG, Carter CS, Read EJ, Rubin M, Goetzman HG, Lizzio EF, Lee YL, Hanson M, Pizzo PA, Hoffman T. Stimulatory effect of counterflow centrifugal elutriation in large-scale separation of peripheral blood monocytes can be reserved by storing the cells at 37°C. J Clin Apheresis. 1991;53:48-53.
16. Davis MG, Huang ES. Transfer and expression of plasmids containing human cytomegalovirus immediate-early gene 1 promoter-enhancer sequences in eukaryotic and prokaryotic cells. Biotechnol Appl Biochem. 1988;10:6-12.
17. Havel RJ, Eder HA. Bragdon JH. The distribution and chemical composition of ulticentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;43:1345-1353.
18. Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A. 1988;85:2805-2809.
19. Liao F, Berliner JA, Mehrabian M, Navab M, Demer LL. Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest. 1991;87:2253-2257.
20. Goreman C, Moffat LF, Howard BH. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cell. Mol Cell Biol. 1982;2:1044-1051.
21. Seed B, Sheen JY. A simple phase-extraction assay for chloramphenicol acetyl transferase activity. Gene. 1988;67:271-277.
22. Waldman WJ, Sneddon JF, Stephens RE, Roberts WH. Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells. J Med Virol. 1989;28:223-230.
23. Waldman WJ, Roberts WH, Davis DH, Williams MV, Sedmak DD, Stephens RE. Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells. Arch Virol. 1991;117:143-164.
24. Waldman WJ, Knight DA, Huang EH, Sedmak DD. Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in-vitro model. J Infect Dis. 1995;171: 263-272.
25. Faruqui RM, DiCorleto PE. Mechanisms of monocyte recruitment and accumulation. Br Heart J. 1994;69(suppl):S19-S29.
26. Shackelford RE, Misra UK, Florine-Casteel K, Thai SF, Pizzo SV, Adams DO. Oxidized low density lipoprotein suppresses activation of NfkB in macrophages via a pertussis toxin-sensitive signaling mechanism. J Biol Chem. 1995;270:3475-3478.
27. Maziere C, Auclair M, Djavaheri-Mergny M, Packer L, Maziere JC. Oxidized low density lipoprotein induces activation of NfkB in fibroblasts, endothelial cells and smooth muscle cells. Biochem Mol Biol Int. 1996;39:1201-1207.
28. Peng HB, Ravjavashisth TB, Libby P, Liao JK. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem. 1995;270:17050-17055.
29. Parhami F, Fang ZT, Fogelman AM, Andalibi A, Territo MC, Berliner JA. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cAMP. J Clin Invest. 1993;92:471-478.
30. Ghazal PJ, Nelson JA. Transcription factors and viral regulatory proteins as potential mediators of human cytomegalovirus pathogenesis. In: Beker Y, Darai G, eds. Molecular Aspects of Human Cytomegalovirus Diseases. Berlin, Germany: Springer-Verlag; 1993:360-383.
31. Ares MPS, Kailin B, Eriksson P, Nilsson J. Oxidized LDL induces transcription factor activator protein-1 but inhibits activation of nuclear factor-κB in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995;15:1584-1590.
32. Ohlsson BG, Englund MCO, Karlsson ALK, Knutsen E, Erixon C, Skribeck H, Liu Y, Bondjers G, Wiklund O. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of NfκB to DNA and the subsequent expression of tumor necrosis factor-α and interleukin-1β in macrophages. J Clin Invest. 1996;98:78-89.
33. Kume N, Cybulsky MI, Gimbrone MA. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138-1144.
34. Scholz M, Cinati J, Gross V, Vogel JU, Blaheta RA, Freisleben HJ, Markus BH, Doerr HW. Impact of oxidative stress on human cytomegalovirus replication and on cytokine-mediated stimulation of endothelial cells. Transplantation. 1996;61:1763-1770.
35. Speir E, Shibutani T, Yu Z-X, Ferrans V, Epstein SE. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection. Circ Res. 1996;79:1143-1152.
36. Epstein SE, Speir E, Zhou YF, Guetta E, Leon M, Finkel T. The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet. 1996;348:s13-s17.
37. Hendrix MGR, Dormans PH, Kitslaar P, Bosman F, Bruggeman CA. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am J Pathol. 1989:134:23-28.
38. Melnick JL, Hu C, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol. 1994;42:170-174.
39. Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, DeBakey ME. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet. 1983;2:644-647.
40. Grattan MT. Accelerated graft atherosclerosis following cardiac transplantation: clinical perspectives. Clin Cardiol. 1991;14(suppl 11):16-20.
41. Fabricant CG, Fabricant J, Minick CR, Litrenta MM. Herpesvirus-induced atherosclerosis in chickens. Fed Proc. 1983;42:2476-2479.
42. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med. 1996;335:624-630.
43. Albrecht T, Boldogh I, Fons M, Lee CH, AbuBakar SN, Russell JM, An WW. Cell-activation responses to cytomegalovirus infection: relalionship to the phasing of CMV replication and to the induction of cellular damage. In: Harris JR, ed. Subcellular Biochemistry. New York, NY: Plenum Publishing Corp; 1989:157-202.
44. Alcami J, Barzu T, Michelson S. Induction of an endothelial cell growth factor by human cytomegalovirus infection of fibroblasts. J Gen Virol. 1991;72:2765-2770.
45. Gonczol E, Plotkin S. Cells infected with human cytomegalovirus release a factor(s) that stimulates cell DNA synthesis. J Gen Virol. 1984;65:1833-1837.
46. Waldman WJ, Knight DA. Cytokine-mediated induction of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells. Am J Pathol. 1996;148:105-119.
47. Kovacs AK, Weber ML, Burns LJ, Jacob HS, Vercellotti GM. Cytoplasmic sequestration of p53 in cytomegalovirus-infected endothelial cells. Am J Pathol. 1996;149:1531-1539.
48. Muganda P, Mendoza O, Hernandez J, Quian Q. Human cytomegalovirus elevates levels of cellular protein p53 in infected fibroblasts. J Virol. 1994;68:8208-8034.
49. Zhu H, Shen Y, Shenk T. Human cytomegalovirus IE1 and IF2 proteins block apoptosis. J Virol. 1995;69:7960-7970.
50. Grundy JU, Downes KL. Up-regulation of LFA-3 and I-CAM-1 on the surface of fibroblasts infected with cytomegalovirus. Immunology. 1993;78:405-412.
51. Span AH, Van Dam-Mieras MCE, Mullers W, Endert J, Muller AD, Bruggeman CA. The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells. Eur J Clin Invest. 1989;21:331-338.
52. Van Dam-Mieras MCE. Muller AD, van Hinsbergh VWM, Mullers WJHA, Bomans PHH, Bruggeman CA. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost. 1992;68:364-370.
53. Pryzdial ELG, Wright JF. Prothrombinase assembly on an enveloped virus: evidence that cytomegalovirus surface contains procoagulant phospholipid. Blood. 1994;84:3749-3757.
54. Kowalik TF, Wing B, Haskill JS, Azizkhan JC, Baldwin AS, Huang ES. Multiple mechanisms are implicated in the regulation of NFκB activity during human cytomegalovirus infection. Proc Natl Acad Sci U S A. 1993;90:1107-1111.
55. Yurochko AD, Kowalik TF, Huong SH, Huang ES. Human cytomegalovirus upregutates NF-κB p105/p50 and p65 promoters. J Virol. 1995;69:5391-5400.
56. Hajjar DP, Fabricant CG, Minick CR, Fabricant J. Virus-induced atherosclerosis: herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am J Pathol. 1986;122:62-70.
57. Hajjar DP, Pomerantz KB, Falcone DJ, Weksler BB, Grant AJ. Herpes simplex virus infection in human arterial cells: implications in atherosclerosis. J Clin Invest. 1987;80:1317-1321.
58. Zhou YF, Guetta E, Yu ZX, Finkel T, Epstein SE. Human cytomegalovirus increases modified LDL uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J Clin Invest. 1996;98:2129-2138.